You are here
Glaxo may consider spinoffs after Novartis deal is completed
GLAXOSMITHKLINE Plc chief executive officer Andrew Witty is willing to consider suggestions made by investors to break up the company - although it may not happen for at least a year or two.
A deal with Novartis AG that closed in March created market-leading businesses in
- CALL +65 6388 3838
- EMAIL email@example.com